Hims & Hers Health (HIMS) Accumulated Expenses (2019 - 2026)
Hims & Hers Health (HIMS) reported Accumulated Expenses of $90.7 million for Q1 2026, up 59.36% on a YoY basis from $56.9 million in Q1 2025, and up 15.57% sequentially from $78.5 million in Q4 2025.
Hims & Hers Health (HIMS) Accumulated Expenses (2019 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 8 years of Accumulated Expenses data on file, last reported at $90.7 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses rose 59.36% year-over-year to $90.7 million; the trailing twelve-month figure through Mar 2026 stood at $90.7 million (up 59.36% YoY), and the FY2025 full-year result was $78.5 million, up 48.11% from the prior year.
- Accumulated Expenses grew to $90.7 million in Q1 2026, from $78.5 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $90.7 million in Q1 2026 to a low of $9.1 million in Q1 2022.
- A 5-year average of $39.1 million and a median of $28.9 million in 2024 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses rose 2.08% in 2022 and surged 132.74% in 2023, its largest moves.
- Tracing HIMS's Accumulated Expenses over 5 years: stood at $12.4 million in 2022, then surged by 132.74% to $29.0 million in 2023, then jumped by 82.98% to $53.0 million in 2024, then jumped by 48.11% to $78.5 million in 2025, then grew by 15.57% to $90.7 million in 2026.
- Business Quant data shows HIMS's Accumulated Expenses at $90.7 million in Q1 2026, $78.5 million in Q4 2025, and $80.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 90.74 Mn |
| Dec 31, 2025 | 78.52 Mn |
| Sep 30, 2025 | 80.13 Mn |
| Jun 30, 2025 | 65.67 Mn |
| Mar 31, 2025 | 56.94 Mn |
| Dec 31, 2024 | 53.01 Mn |
| Sep 30, 2024 | 43.22 Mn |
| Jun 30, 2024 | 28.95 Mn |
| Mar 31, 2024 | 26.71 Mn |
| Dec 31, 2023 | 28.97 Mn |
| Sep 30, 2023 | 27.36 Mn |
| Jun 30, 2023 | 19.61 Mn |
| Mar 31, 2023 | 14.12 Mn |
| Dec 31, 2022 | 12.45 Mn |
| Sep 30, 2022 | 17.15 Mn |
| Jun 30, 2022 | 11.81 Mn |
| Mar 31, 2022 | 9.09 Mn |
| Dec 31, 2021 | 12.19 Mn |
| Sep 30, 2021 | 11.21 Mn |
| Jun 30, 2021 | 10.76 Mn |